Cyclic 3',5'-nucleotide phosphodiesterases: potential targets for anticancer therapy.
about
Stereoselective synthesis of novel pyrazole derivatives using tert-butansulfonamide as a chiral auxiliaryGrowth arrest and forced differentiation of human primary glioblastoma multiforme by a novel small molecule.The cAMP-specific phosphodiesterase TbPDE2C is an essential enzyme in bloodstream form Trypanosoma bruceiInhibition of phosphodiestrase 9 induces cGMP accumulation and apoptosis in human breast cancer cell lines, MCF-7 and MDA-MB-468.Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activityPhosphodiesterase 3/4 inhibitor zardaverine exhibits potent and selective antitumor activity against hepatocellular carcinoma both in vitro and in vivo independently of phosphodiesterase inhibition.Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancersTargeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression.Targeting cancer with phosphodiesterase inhibitors.The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatmentDownregulation of phosphodiesterase 4B (PDE4B) activates protein kinase A and contributes to the progression of prostate cancer.Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.Differential phosphodiesterase expression and cytosolic Ca2+ in human CNS tumour cells and in non-malignant and malignant cells of rat origin.Inhibition of Cyclic Adenosine Monophosphate-Specific Phosphodiesterase by Various Food Plant-Derived Phytotherapeutic Agents.DHA induces apoptosis of human malignant breast cancer tissues by the TLR-4/PPAR-α pathways.
P2860
Q27677514-F277B6AF-DD74-46B4-AC1D-F44C2AB9B9E3Q33840263-C39FD250-537C-41AE-AB2E-37CA231D45E2Q34047854-39DDD0D5-D9FE-4D65-AC6F-2C27078B5670Q34216942-9B906049-B494-4577-BBFA-2CBA501F52AAQ34416260-5690DF13-F007-4795-9B7C-0C28F5C580C4Q35112099-A6BEE650-F8AF-4A2B-8F1C-3A40B1B5FF88Q36334968-DED4109A-B592-4456-8376-E0DAB9162E02Q36762760-09765BF7-D417-4AB3-A3E3-FB47368238A7Q37041337-654AB020-A293-4A80-BDCB-0193BE4C9C8DQ37650389-89410B88-ED77-4A62-9DB1-2CABDF318A1DQ37693485-42D2ED0B-3212-4618-BE46-5AC76CF30AECQ39359743-F84C25E5-2D72-4C9C-AD2F-CA0FF9BA6C87Q39360659-0DBAA3A9-4A0B-4DF9-A228-615C242C4ADDQ40437564-64418318-CA01-4904-AC62-8120B08DB365Q47853676-E0A8501B-435C-4B30-9372-96B667C817C8Q49562948-2FBC915A-C69C-44DC-B99B-DF7E0FA78001
P2860
Cyclic 3',5'-nucleotide phosphodiesterases: potential targets for anticancer therapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cyclic 3',5'-nucleotide phosphodiesterases: potential targets for anticancer therapy.
@ast
Cyclic 3',5'-nucleotide phosphodiesterases: potential targets for anticancer therapy.
@en
Cyclic 3',5'-nucleotide phosphodiesterases: potential targets for anticancer therapy.
@nl
type
label
Cyclic 3',5'-nucleotide phosphodiesterases: potential targets for anticancer therapy.
@ast
Cyclic 3',5'-nucleotide phosphodiesterases: potential targets for anticancer therapy.
@en
Cyclic 3',5'-nucleotide phosphodiesterases: potential targets for anticancer therapy.
@nl
prefLabel
Cyclic 3',5'-nucleotide phosphodiesterases: potential targets for anticancer therapy.
@ast
Cyclic 3',5'-nucleotide phosphodiesterases: potential targets for anticancer therapy.
@en
Cyclic 3',5'-nucleotide phosphodiesterases: potential targets for anticancer therapy.
@nl
P2093
P356
P1476
Cyclic 3',5'-nucleotide phosphodiesterases: potential targets for anticancer therapy.
@en
P2093
P304
P356
10.1021/TX000090L
P577
2000-10-01T00:00:00Z